followed by loading the D-proline on the surfaces of nanocapsules to obtain matrine@chitosan-D-proline (Mat@CS-Pro) multifunctional nanocapsules. The morphology and composition of the nanocapsules ...

This important manuscript proposes a new strategy for the identification of new mechanisms of drug resistance based on SAturated Transposon Analysis in Yeast (SATAY), a powerful transposon sequencing ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other firms that posted double-digit gains on Thursday. Wall Street’s main indices finished in ...

In this article, we are going to take a look at where Tempus AI (NASDAQ:TEM) stands against the other stocks. Stock gains always get people talking, and 2025 is no exception. Markets have moved ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14 ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other large-cap stocks. We previously covered 10 Large-Cap Stocks Insiders Are Buying Recently.

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing. The ...

Tempus AI (NASDAQ:TEM) went public in June 2024. The company reminds me a lot of Invitae, especially with all the management's talk about being a one-stop-shop like Amazon. However, the fact that ...